Advertisement

Topics

BioTime Incorporated Company Profile

03:43 EDT 20th September 2017 | BioPortfolio

BioTime, Inc. (OTCBB: BTIM), based in Emeryville, California, is engaged in the research and development of aqueous-based synthetic solutions that may be used as plasma expanders, organ preservation solutions, or solutions to replace blood volume during low temperature surgery. These products are intended for several important medical applications including: the treatment of hypovolemia caused by surgical blood loss the emergency treatment of blood loss due to traumatic injury the replacement of all of a patient's circulating blood during cardiac surgery and neurosurgery that involve lowering the patient's body temperature to hypothermic levels the preservation of body organs and tissues awaiting transplant other biomedical applications Because the Company's solutions are synthetic, they can be sterilized under high temperatures and pressures, and will not pose a risk of transmitting infectious agents.

Location

6121 Hollis Street
Emeryville
94608
United States of America

Contact

Phone: 510.350.2940
Fax: 510.350.2948


News Articles [58 Associated News Articles listed on BioPortfolio]

BioTime awarded $1.5M grant from the NIH

BioTime, a clinical-stage biotechnology company focused on developing and commercializing products addressing degenerative diseases, has been awarded a grant of up to $1.56 million from the Small Busi...

BioTime Reports First Quarter Results And Recent Corporate Accomplishments

ALAMEDA, Calif--(BUSINESS WIRE)--BioTime, Inc. (NYSE MKT and TASE: BTX), a clinical-stage biotechnology company developing and commercializing products addressing degenerative diseases, to...

BioTime to Announce Top Line Data From the Company's Renevia European Pivotal trial

Schedules Conference Call for 4:30pm ET on June 14, 2017 BioTime, Inc. (NYSE MKT: BTX), a clinical-stage biotechnology company developing and commercializing products addressing degenerative disea...

BioTime???s Renevia Achieves Primary Endpoint In European Pivotal Trial

Data Reinforce Renevias Potential in Multi-Billion Dollar Facial Aesthetics Market BioTime on Track to File for Renevia CE Mark by End of 2017 Conference Call ...

BioTime to Present at the LD Micro San Francisco Summit

BioTime, Inc. (NYSE American: BTX), a clinical-stage biotechnology company focused on developing and commercializing products addressing degenerative diseases, today announced tha...

BioTime Presents Retinal Restoration Data At Association for Research in Vision & Ophthalmology

Demonstrates Ability to Grow Full-Thickness, 3-D Retinal Tissue Tissue is Highly Similar to Natural Human Tissue ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE MKT: BTX)...

BioTime to Present at the Rodman & Renshaw Annual Global Investment Conference

BioTime, Inc. (NYSE American: BTX), a clinical-stage biotechnology company focused on developing and commercializing products addressing degenerative diseases, today announced tha...

BioTime to Present at 16th National Life Sciences and Biotechnology Week (MIXiii BIOMED)

BioTime, Inc. (NYSE MKT: BTX and TASE: BTX), a clinical-stage biotechnology company developing and commercializing products addressing degenerative diseases, today announced that...

PubMed Articles [1 Associated PubMed Articles listed on BioPortfolio]

AERODYNAMIC PROPERTIES AND IN SILICO DEPOSITION OF MELOXICAM POTASSIUM INCORPORATED IN A CARRIER-FREE DPI PULMONARY SYSTEM.

Dry powder inhalers (DPIs) have been among the fastest developing inhaler forms in the past decades. Researches are focusing on the formulation of carrier-free powders to obtain a higher deep-lung dep...

Clinical Trials [0 Results]

None

Companies [42 Associated Companies listed on BioPortfolio]

BioTime, Inc.

BioTime, headquartered in Alameda, California, is a biotechnology company focused on regenerative medicine and blood plasma volume expanders. Its broad platform of stem cell techn...

BioTime, Inc. and Abcodia Ltd.

BioTime is a biotechnology company engaged in research and product development in the field of regenerative medicine. Regenerative medicine refers to therapies based on stem cell ...

BioTime Incorporated

BioTime, Inc. (OTCBB: BTIM), based in Emeryville, California, is engaged in the research and development of aqueous-based synthetic solutions that may be used as plasma expanders, organ preservation s...

PRAECIS PHARMACEUTICALS INCORPORATED

PRAECIS PHARMACEUTICALS INCORPORATED is a biopharmaceutical company focused on the discovery and development of novel compounds to address unmet medical needs or improve existing therapies.PRAECIS has...

Pharmapraxis

Founded in 2008 by the Axis Biotec Brasil™ group (www.axisbiotec.com.br), PharmaPraxis has incorporated technologies, and will develop and launch biologic products in Brazil....

More Information about "BioTime Incorporated" on BioPortfolio

We have published hundreds of BioTime Incorporated news stories on BioPortfolio along with dozens of BioTime Incorporated Clinical Trials and PubMed Articles about BioTime Incorporated for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of BioTime Incorporated Companies in our database. You can also find out about relevant BioTime Incorporated Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Blood
Blood is a specialized bodily fluid that delivers necessary substances to the body's cells (in animals) – such as nutrients and oxygen – and transports waste products away from those same cells.  In vertebrates, it is composed of blo...

Anxiety Disorders
Anxiety is caused by stress. It is a natural reaction, and is beneficial in helping us deal with tense situations and pressure. It is deterimental when is becomes an excessive, irrational dread of everyday situations. The most common types of anxiety di...


Corporate Database Quicklinks



Searches Linking to this Company Record